S&P 500   3,371.08 (+0.32%)
DOW   28,103.79 (+1.12%)
QQQ   268.02 (-0.85%)
AAPL   445.60 (-1.18%)
MSFT   205.15 (-1.49%)
FB   263.21 (+0.08%)
GOOGL   1,486.73 (-0.67%)
AMZN   3,119.01 (-0.93%)
NVDA   441.65 (-1.11%)
CGC   17.48 (-2.51%)
BABA   251.27 (+1.26%)
TSLA   1,397.48 (-1.49%)
GE   6.90 (+3.45%)
MU   49.09 (-0.12%)
AMD   79.83 (-2.93%)
T   30.63 (+1.42%)
F   7.35 (+3.52%)
ACB   10.08 (-1.37%)
GILD   68.85 (+0.50%)
NFLX   473.85 (-1.97%)
DIS   131.22 (+1.89%)
BAC   27.60 (+3.92%)
BA   189.00 (+5.35%)
S&P 500   3,371.08 (+0.32%)
DOW   28,103.79 (+1.12%)
QQQ   268.02 (-0.85%)
AAPL   445.60 (-1.18%)
MSFT   205.15 (-1.49%)
FB   263.21 (+0.08%)
GOOGL   1,486.73 (-0.67%)
AMZN   3,119.01 (-0.93%)
NVDA   441.65 (-1.11%)
CGC   17.48 (-2.51%)
BABA   251.27 (+1.26%)
TSLA   1,397.48 (-1.49%)
GE   6.90 (+3.45%)
MU   49.09 (-0.12%)
AMD   79.83 (-2.93%)
T   30.63 (+1.42%)
F   7.35 (+3.52%)
ACB   10.08 (-1.37%)
GILD   68.85 (+0.50%)
NFLX   473.85 (-1.97%)
DIS   131.22 (+1.89%)
BAC   27.60 (+3.92%)
BA   189.00 (+5.35%)
S&P 500   3,371.08 (+0.32%)
DOW   28,103.79 (+1.12%)
QQQ   268.02 (-0.85%)
AAPL   445.60 (-1.18%)
MSFT   205.15 (-1.49%)
FB   263.21 (+0.08%)
GOOGL   1,486.73 (-0.67%)
AMZN   3,119.01 (-0.93%)
NVDA   441.65 (-1.11%)
CGC   17.48 (-2.51%)
BABA   251.27 (+1.26%)
TSLA   1,397.48 (-1.49%)
GE   6.90 (+3.45%)
MU   49.09 (-0.12%)
AMD   79.83 (-2.93%)
T   30.63 (+1.42%)
F   7.35 (+3.52%)
ACB   10.08 (-1.37%)
GILD   68.85 (+0.50%)
NFLX   473.85 (-1.97%)
DIS   131.22 (+1.89%)
BAC   27.60 (+3.92%)
BA   189.00 (+5.35%)
S&P 500   3,371.08 (+0.32%)
DOW   28,103.79 (+1.12%)
QQQ   268.02 (-0.85%)
AAPL   445.60 (-1.18%)
MSFT   205.15 (-1.49%)
FB   263.21 (+0.08%)
GOOGL   1,486.73 (-0.67%)
AMZN   3,119.01 (-0.93%)
NVDA   441.65 (-1.11%)
CGC   17.48 (-2.51%)
BABA   251.27 (+1.26%)
TSLA   1,397.48 (-1.49%)
GE   6.90 (+3.45%)
MU   49.09 (-0.12%)
AMD   79.83 (-2.93%)
T   30.63 (+1.42%)
F   7.35 (+3.52%)
ACB   10.08 (-1.37%)
GILD   68.85 (+0.50%)
NFLX   473.85 (-1.97%)
DIS   131.22 (+1.89%)
BAC   27.60 (+3.92%)
BA   189.00 (+5.35%)
Log in

NYSE:IVCInvacare Stock Price, Forecast & News

$7.18
-0.06 (-0.83 %)
(As of 08/11/2020 11:00 AM ET)
Add
Compare
Today's Range
$7.15
Now: $7.18
$7.32
50-Day Range
$5.95
MA: $6.68
$7.39
52-Week Range
$3.90
Now: $7.18
$11.63
Volume1,116 shs
Average Volume310,956 shs
Market Capitalization$247.14 million
P/E RatioN/A
Dividend Yield0.70%
Beta1.22
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Read More
Invacare logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP46120310
Phone440-329-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$927.96 million
Cash Flow$0.10 per share
Book Value$8.20 per share

Profitability

Net Income$-53,330,000.00

Miscellaneous

Employees3,900
Market Cap$247.14 million
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$7.18
-0.06 (-0.83 %)
(As of 08/11/2020 11:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IVC News and Ratings via Email

Sign-up to receive the latest news and ratings for IVC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Invacare (NYSE:IVC) Frequently Asked Questions

How has Invacare's stock price been impacted by COVID-19?

Invacare's stock was trading at $6.05 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IVC shares have increased by 18.7% and is now trading at $7.18.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Invacare?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Invacare
.

When is Invacare's next earnings date?

Invacare is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Invacare
.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) announced its quarterly earnings data on Wednesday, August, 5th. The health services provider reported ($0.21) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.27) by $0.06. The health services provider earned $196.30 million during the quarter, compared to the consensus estimate of $196 million. Invacare had a negative return on equity of 9.36% and a negative net margin of 4.82%. During the same quarter in the previous year, the business earned ($0.31) earnings per share.
View Invacare's earnings history
.

How often does Invacare pay dividends? What is the dividend yield for Invacare?

Invacare declared a quarterly dividend on Thursday, February 20th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.0125 per share on Friday, April 17th. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date is Thursday, April 2nd.
View Invacare's dividend history
.

What guidance has Invacare issued on next quarter's earnings?

Invacare issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $810-840 million, compared to the consensus revenue estimate of $897.99 million.

What price target have analysts set for IVC?

2 equities research analysts have issued 1-year price targets for Invacare's stock. Their forecasts range from $11.00 to $17.00. On average, they expect Invacare's share price to reach $14.00 in the next year. This suggests a possible upside of 95.0% from the stock's current price.
View analysts' price targets for Invacare
.

Has Invacare been receiving favorable news coverage?

Media headlines about IVC stock have been trending neutral this week, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Invacare earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave news articles about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about Invacare
.

Are investors shorting Invacare?

Invacare saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 4,750,000 shares, an increase of 6.5% from the July 15th total of 4,460,000 shares. Based on an average daily volume of 392,900 shares, the short-interest ratio is currently 12.1 days. Currently, 14.5% of the company's shares are short sold.
View Invacare's Short Interest
.

Who are some of Invacare's key competitors?

What other stocks do shareholders of Invacare own?

Who are Invacare's key executives?

Invacare's management team includes the following people:
  • Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 51)
  • Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 56)
  • Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel & Sec. (Age 61)
  • Ms. Darcie L. Karol, Sr. VP of HR (Age 52)
  • Mr. Ralf A. Ledda, Sr. VP & GM of EMEA (Age 51)

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Who are Invacare's major shareholders?

Invacare's stock is owned by many different institutional and retail investors. Top institutional shareholders include Russell Investments Group Ltd. (3.36%), Paradigm Capital Management Inc. NY (2.30%), Principal Financial Group Inc. (0.81%), WINTON GROUP Ltd (0.54%), Wedge Capital Management L L P NC (0.49%) and Monarch Partners Asset Management LLC (0.31%). Company insiders that own Invacare stock include Clifford D Nastas, Kathleen P Leneghan and Matthew E Monaghan.
View institutional ownership trends for Invacare
.

Which major investors are selling Invacare stock?

IVC stock was sold by a variety of institutional investors in the last quarter, including Trexquant Investment LP, and UBS Group AG.
View insider buying and selling activity for Invacare
.

Which major investors are buying Invacare stock?

IVC stock was purchased by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, Russell Investments Group Ltd., Wedge Capital Management L L P NC, WINTON GROUP Ltd, Monarch Partners Asset Management LLC, Eqis Capital Management Inc., Principal Financial Group Inc., and Emerald Advisers LLC. Company insiders that have bought Invacare stock in the last two years include Clifford D Nastas, Kathleen P Leneghan, and Matthew E Monaghan.
View insider buying and selling activity for Invacare
.

How do I buy shares of Invacare?

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Invacare's stock price today?

One share of IVC stock can currently be purchased for approximately $7.18.

How big of a company is Invacare?

Invacare has a market capitalization of $247.14 million and generates $927.96 million in revenue each year. The health services provider earns $-53,330,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. Invacare employs 3,900 workers across the globe.

What is Invacare's official website?

The official website for Invacare is www.invacare.com.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44035. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.